Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Silence Therapeutics plc

NASDAQ: SLN · Life Sciences · 3 alerts · CIK 1479615

Share price
$19.80Close, Nov 16
Market cap
$3.69B
Shares outstanding
186.61MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Silence Therapeutics plc filings on SEC EDGAR ↗

6:03 AM ET 10-Q
Financial Results

Silence Therapeutics Q3 2026 Results: Net Loss of $12.4M, Loss Narrows

Silence Therapeutics reported a net loss of $39.7 million for the nine months ended September 30, 2026, a significant improvement from the $76.8 million loss in the prior year period. The company strengthened its balance sheet through a major share issuance in the third quarter, bringing cash and cash equivalents to $247.7 million, which management believes will fund operations until at least 2028.

Key figure
Net loss $12.4M

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.